Diminishing returns of disease-modifying treatment in older participants of multiple sclerosis clinical trials.
Saved in:
| Title: | Diminishing returns of disease-modifying treatment in older participants of multiple sclerosis clinical trials. |
|---|---|
| Authors: | Strijbis E; Amsterdam UMC, Amsterdam, The Netherlands., Mostert J; Department of Neurology, Rijnstate Hospital, Arnhem, The Netherlands., D'Haeseleer M; Universitair Ziekenhuis Brussel, Brussels, Belgium; National Multiple Sclerosis Center, Melsbroek, Belgium., Moral E; Neurology, Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain., Brieva Ruiz L; Neuroimmunology Group, Department of Neurology, Hospital Universitari Arnau de Vilanova, Lleida, Spain., Comtois J; Université de Montreal, Montreal, QC, Canada., Killestein J; Amsterdam UMC, Amsterdam, The Netherlands., Repovic P; Swedish Neuroscience Institute Multiple Sclerosis Center, Seattle, WA, USA., McPherson T; Biostatistics and Bioinformatics, Emory University, Atlanta, GA, USA., Cutter G; Department of Biostatistics, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA., Koch M; Clinical Neurosciences, University of Calgary, Calgary, AB, Canada. |
| Source: | Multiple sclerosis (Houndmills, Basingstoke, England) [Mult Scler] 2026 Apr; Vol. 32 (4), pp. 429-439. Date of Electronic Publication: 2026 Mar 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9509185 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0970 (Electronic) Linking ISSN: 13524585 NLM ISO Abbreviation: Mult Scler Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
